HIV/HCV coinfection exacerbates ESLD risk.
Highleyman
Liz
L
D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use; D018791:CD4 Lymphocyte Count; D005260:Female; D015658:HIV Infections / Q000150:complications*; D006526:Hepatitis C / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D017114:Liver Failure, Acute / Q000150:complications*; D008297:Male; D012307:Risk Factors; D019562:Viral Load
D000998:Antiviral Agents